Newsbot

Hims & Hers Health (HIMS) Could Be 85% Undervalued Following The Eli Lilly Deal

Hims & Hers Health (HIMS) just signed a new agreement with Eli Lilly that allows its users to access branded obesity drugs Zepbound and Foundayo directly through the telehealth platform, including integrated consultations and home delivery. Investor reaction has been mixed in the run up to this Eli Lilly deal, with the 1 day share price return of 8.06% contrasting with a 30 day share price return down 11.98% and a year to date share price return down 22.18%. Capitalize on the renewed focus...

Hims Partnership Could Be A Big Deal For Eli Lilly (LLY)

Eli Lilly and Hims & Hers Health announced a partnership in early November 2026 that lets eligible patients obtain Zepbound and Foundayo on the Hims & Hers telehealth platform at Lilly’s self pay prices, with prescriptions written by independent clinicians and medicines shipped directly to patients’ homes.The move extends Eli Lilly’s obesity portfolio into a large consumer digital channel at the same time the company has lifted 2026 revenue guidance to US$91b to US$92b. This ties demand for...

Tesla: Das Ende des Cybertrucks

Jahrelang nannte Elon Musk seinen Elektropickup das beste Produkt, das Tesla je gebaut hat. Nach elf Rückrufen und jährlich schwindenden Verkäufen kündigt er nun das Aus an.

Hims & Hers Stock After Lilly Weight Loss Drug Deal Has The Bull Case Changed?

Eli Lilly and Company announced an agreement with Hims & Hers Health to offer FDA-approved obesity drugs Zepbound and Foundayo on the Hims & Hers platform, giving eligible telehealth patients access to Lilly’s self-pay prices without leaving the service. The collaboration shifts Hims & Hers weight loss offering fully to branded GLP-1 therapies, removes compounded copies from its model, and ties its telehealth engine directly to a major drugmaker’s obesity portfolio and pricing. This...

US MARKETS CALL: S&P 500 Valuation Dives As Earnings Soar

The stock market dived last week. Investors priced in political backlash against data centers after Democrats swept Congress. We anticipated buying opportunities after the midterm elections, and Thursday’s selloff delivered some. This remains an earnings-led bull market. Valuations are falling while earnings are soaring. We still view the